Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country.
Acceptance
Barriers
Benefits
COVID-19
Coronavirus
Developing country
Jordan
Risk perception
Vaccine
Journal
Clinical and experimental vaccine research
ISSN: 2287-3651
Titre abrégé: Clin Exp Vaccine Res
Pays: Korea (South)
ID NLM: 101592344
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
31
01
2021
accepted:
26
05
2021
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
ppublish
Résumé
Vaccination is a cost-efficient intervention to slow the spread of the coronavirus disease 2019 (COVID-19) pandemic. This study aims to assess the population's willingness to take the COVID-19 vaccine in Jordan and investigate potential determinants of their acceptance. This study used an online survey distributed in November 2020, before introducing the vaccine, with items investigating socio-demographic characteristics, seasonal flu vaccination history, COVID-19 vaccine acceptance once available, and factors affecting their decision-making. Also, "COVID-19 risk perception" and beliefs toward COVID-19 vaccine benefits and barriers were assessed. A total of 2,208 participants completed the survey with a participation rate of 13.1%. The mean±standard deviation age was 33.2±13.5, and 55.7% were females. Study participants were almost equally distributed between willingness, unwillingness, and indecision to take the COVID-19 vaccine (30.4%, 36.4%, and 31.5%, respectively). Younger adults, males, and those who were not married, do not have children, have a bachelor or higher education, employees or being students, healthcare workers, and those who reported receiving flu vaccine had higher rates of COVID-19 vaccine acceptance compared to their counterparts (p<0.001 for each category). COVID-19 risk perception, and perceived vaccine benefits, and barriers were significant predictors of intention. Among those undecided or unwilling to take the COVID-19 vaccine, its safety and side effects were the most common concerns. The low rate of COVID-19 vaccine acceptance in a developing country is alarming, and a significant proportion are indecisive. Interventions to elevate vaccine acceptance by addressing its safety and efficacy and targeting vulnerable groups are recommended.
Identifiants
pubmed: 34222130
doi: 10.7774/cevr.2021.10.2.171
pmc: PMC8217585
doi:
Types de publication
Journal Article
Langues
eng
Pagination
171-182Informations de copyright
© Korean Vaccine Society.
Déclaration de conflit d'intérêts
No potential conflict of interest relevant to this article was reported.
Références
Emerg Infect Dis. 2020 Jul;26(7):1470-1477
pubmed: 32255761
BMC Public Health. 2011 Jan 06;11(1):15
pubmed: 21211000
Vaccine. 2020 Oct 21;38(45):7049-7056
pubmed: 32980199
Innov Pharm. 2012;3(2):1-11
pubmed: 22844651
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Euro Surveill. 2019 Jun;24(26):
pubmed: 31266587
Disaster Med Public Health Prep. 2015 Apr;9(2):207-19
pubmed: 25882127
Health Technol Assess. 2010 Jul;14(34):183-266
pubmed: 20630124
JAMA Netw Open. 2020 Oct 1;3(10):e2025594
pubmed: 33079199
Nat Rev Drug Discov. 2020 Oct;19(10):667-668
pubmed: 32887942
Ann Med Surg (Lond). 2020 Jul 18;57:103-108
pubmed: 32742648
BMC Public Health. 2020 Nov 19;20(1):1742
pubmed: 33213391
N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Int Q Community Health Educ. 2013-2014;34(1):101-17
pubmed: 24366025
Vaccine. 2018 Dec 18;36(52):8158-8164
pubmed: 29331245
Euro Surveill. 2009 Dec 10;14(49):
pubmed: 20003909
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
Biosecur Bioterror. 2009 Sep;7(3):275-90
pubmed: 19775200
Ann Med Surg (Lond). 2020 Dec;60:484-486
pubmed: 33194175
Int J Environ Res Public Health. 2020 Sep 08;17(18):
pubmed: 32911738
Am J Infect Control. 2021 Feb;49(2):137-142
pubmed: 33227323
J Med Internet Res. 2007 Sep 30;9(3):e25
pubmed: 17942387
LGBT Health. 2018 Jul;5(5):325-329
pubmed: 29979642
PLoS One. 2010 Apr 16;5(4):e10199
pubmed: 20421908
Health Promot Pract. 2014 Jul;15(4):556-67
pubmed: 24440920
Med J Aust. 2010 Jan 4;192(1):33-6
pubmed: 20047546